sennoside A has been researched along with epigallocatechin gallate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cale, JM; Emal, CD; Lawrence, DA; Li, SH; North, PR; Puscau, MM; Sanders, KL; Su, EJ; Warnock, M | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
2 other study(ies) available for sennoside A and epigallocatechin gallate
| Article | Year |
|---|---|
Characterization of a novel class of polyphenolic inhibitors of plasminogen activator inhibitor-1.
Topics: Animals; Drug Design; Electrophoresis, Polyacrylamide Gel; Flavonoids; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenols; Plasminogen Activator Inhibitor 1; Polyphenols; Protease Inhibitors; Recombinant Proteins; Serpin E2; Serpins; Surface Plasmon Resonance; Vitronectin | 2010 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |